Free Trial

Revolution Medicines (RVMD) SEC Filings & 10K Form

Revolution Medicines logo
$37.00 -0.19 (-0.51%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$37.39 +0.39 (+1.05%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Revolution Medicines SEC Filings

DateFilerForm TypeView
06/24/2025
6:05 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
3:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:23 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
3:23 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:05 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025
4:25 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Wei Lin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
8:22 AM
Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G
05/15/2025
8:23 AM
Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G/A
05/15/2025
8:24 AM
Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G/A
05/14/2025
11:29 AM
JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G/A
04/28/2025
5:27 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
03/24/2025
3:55 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:32 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
4:40 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:40 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:41 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:42 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:43 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:42 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
4:14 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:47 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:18 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:03 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:00 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:01 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:01 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:02 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:02 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:44 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
10:25 AM
JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G
01/22/2025
4:30 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
3:50 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:08 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:09 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:06 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
$100 Trillion “AI Metal” Found in American Ghost Town (Ad)

Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.

Click here to get the details on this virtual monopoly.
12/16/2024
8:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:42 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:01 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:39 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:57 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
3:18 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
8:37 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form FWP
12/02/2024
4:21 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
12/02/2024
6:30 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
9:52 AM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/06/2024
4:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:05 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:30 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
5:43 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
5:05 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:29 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:31 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:03 AM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:16 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:23 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Weber Barbara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:16 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:06 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:41 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:22 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:37 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:15 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:24 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:23 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:15 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:48 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:07 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
08/02/2024
4:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:29 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:05 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
White House to reset Social Security? (Ad)

Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.

And it could have a major impact on how you collect Social Security - Click here to understand what'
07/15/2024
3:27 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
7:03 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:36 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:36 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:19 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:19 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RVMD) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners